Telomeres in lung disease

Translational Research

Volumn 162, Issue 6, 2013, Pages 343-352

  Gansner, John M ^a   Rosas, Ivan O ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMETELSTAT; NUCLEOTIDYLTRANSFERASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE RNA COMPONENT; TERTOMOTIDE; UNCLASSIFIED DRUG;

CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); DRUG MEGADOSE; DYSKERATOSIS CONGENITA; EMPHYSEMA; FIBROSING ALVEOLITIS; GENE MUTATION; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LUNG DISEASE; LUNG NON SMALL CELL CANCER; LUNG TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TELOMERE;

EID: 84887990028     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.04.001     Document Type: Review

References (155)

1. E.H. Blackburn Telomeres and telomerase: the means to the end [Nobel lecture] Angew Chem Int Ed Engl 49 2010 7405 7421
2. C.W. Greider Telomerase discovery: the excitement of putting together pieces of the puzzle [Nobel lecture] Angew Chem Int Ed Engl 49 2010 7422 7439
3. J.W. Szostak DNA ends: just the beginning [Nobel lecture] Angew Chem Int Ed Engl 49 2010 7386 7404
4. R.K. Moyzis, J.M. Buckingham, and L.S. Cram A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes Proc Natl Acad Sci U S A 85 1988 6622 6626
5. E.H. Blackburn, and J.G. Gall A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena J Mol Biol 120 1978 33 53
6. J.W. Szostak, and E.H. Blackburn Cloning yeast telomeres on linear plasmid vectors Cell 29 1982 245 255
7. R. Ohki, T. Tsurimoto, and F. Ishikawa In vitro reconstitution of the end replication problem Mol Cell Biol 21 2001 5753 5766
8. B. McClintock The stability of broken ends of chromosomes in Zea mays Genetics 26 1941 234 282
9. M. Armanios, and E.H. Blackburn The telomere syndromes Nat Rev Genet 13 2012 693 704
10. N.S. Young Telomere biology and telomere diseases: implications for practice and research Hematol Am Soc Hematol Educ Program 2010 2010 30 35
11. R. Calado, and N. Young Telomeres in disease F1000 Med Rep 4 2012 8
12. R.T. Calado, and N.S. Young Telomere diseases N Engl J Med 361 2009 2353 2365
13. M. Armanios Syndromes of telomere shortening Annu Rev Genomics Hum Genet 10 2009 45 61
14. G. Aubert, and P.M. Lansdorp Telomeres and aging Physiol Rev 88 2008 557 579
15. H.J. Muller The remaking of chromosomes Collecting Net XIII 1938 182 195
16. T.M. Nakamura, G.B. Morin, and K.B. Chapman Telomerase catalytic subunit homologs from fission yeast and human Science 277 1997 955 959
17. M. Meyerson, C.M. Counter, and E.N. Eaton hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization Cell 90 1997 785 795
18. A. Kilian, D.D. Bowtell, and H.E. Abud Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types Hum Mol Genet 6 1997 2011 2019
19. L. Harrington, W. Zhou, and T. McPhail Human telomerase contains evolutionarily conserved catalytic and structural subunits Genes Dev 11 1997 3109 3115
20. S.L. Weinrich, R. Pruzan, and L. Ma Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT Nat Genet 17 1997 498 502
21. J. Feng, W.D. Funk, and S.S. Wang The RNA component of human telomerase Science 269 1995 1236 1241
22. C.W. Greider, and E.H. Blackburn A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis Nature 337 1989 331 337
23. K. Collins, R. Kobayashi, and C.W. Greider Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme Cell 81 1995 677 686
24. S.B. Cohen, M.E. Graham, G.O. Lovrecz, N. Bache, P.J. Robinson, and R.R. Reddel Protein composition of catalytically active human telomerase from immortal cells Science 315 2007 1850 1853
25. D. Fu, and K. Collins Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation Mol Cell 28 2007 773 785
26. K. Collins, and J.R. Mitchell Telomerase in the human organism Oncogene 21 2002 564 579
27. L. Hayflick The limited in vitro lifetime of human diploid cell strains Exp Cell Res 37 1965 614 636
28. A.M. Olovnikov A theory of marginotomy: the incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon J Theor Biol 41 1973 181 190
29. J.A. Stewart, M.F. Chaiken, F. Wang, and C.M. Price Maintaining the end: roles of telomere proteins in end-protection, telomere replication and length regulation Mutat Res 730 2012 12 19
30. F.W. Lung, P.L. Fan, N.C. Chen, and B.C. Shu Telomeric length varies with age and polymorphisms of the MAOA gene promoter in peripheral blood cells obtained from a community in Taiwan Psychiatr Genet 15 2005 31 35
31. J.T. Cronkhite, C. Xing, and G. Raghu Telomere shortening in familial and sporadic pulmonary fibrosis Am J Respir Crit Care Med 178 2008 729 737
32. N.D. Hastie, M. Dempster, M.G. Dunlop, A.M. Thompson, D.K. Green, and R.C. Allshire Telomere reduction in human colorectal carcinoma and with ageing Nature 346 1990 866 868
33. J. Lindsey, N.I. McGill, L.A. Lindsey, D.K. Green, and H.J. Cooke In vivo loss of telomeric repeats with age in humans Mutat Res 256 1991 45 48
34. K. Takubo, K. Nakamura, and N. Izumiyama Telomere shortening with aging in human esophageal mucosa Age 22 1999 95 99
35. R.C. Allsopp, H. Vaziri, and C. Patterson Telomere length predicts replicative capacity of human fibroblasts Proc Natl Acad Sci U S A 89 1992 10114 10118
36. H. Vaziri, W. Dragowska, R.C. Allsopp, T.E. Thomas, C.B. Harley, and P.M. Lansdorp Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age Proc Natl Acad Sci U S A 91 1994 9857 9860
37. A.M. Valdes, T. Andrew, and J.P. Gardner Obesity, cigarette smoking, and telomere length in women Lancet 366 2005 662 664
38. D.T. Eisenberg, K.D. Salpea, C.W. Kuzawa, M.G. Hayes, and S.E. Humphries Substantial variation in qPCR measured mean blood telomere lengths in young men from eleven European countries Am J Hum Biol 23 2011 228 231
39. S.C. Hunt, W. Chen, and J.P. Gardner Leukocyte telomeres are longer in African Americans than in whites: the National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study Aging Cell 7 2008 451 458
40. M.T. Hemann, M.A. Strong, L.Y. Hao, and C.W. Greider The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability Cell 107 2001 67 77
41. T.E. King Jr., A. Pardo, and M. Selman Idiopathic pulmonary fibrosis Lancet 378 2011 1949 1961
42. E.B. Meltzer, and P.W. Noble Idiopathic pulmonary fibrosis Orphanet J Rare Dis 3 2008 8
43. G. Raghu, H.R. Collard, and J.J. Egan An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 2011 788 824
44. L. Nalysnyk, J. Cid-Ruzafa, P. Rotella, and D. Esser Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature Eur Respir Rev 21 2012 355 361
45. D.B. Coultas, R.E. Zumwalt, W.C. Black, and R.E. Sobonya The epidemiology of interstitial lung diseases Am J Respir Crit Care Med 150 1994 967 972
46. E.R. Fernandez Perez, C.E. Daniels, and D.R. Schroeder Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study Chest 137 2010 129 137
47. G. Raghu, D. Weycker, J. Edelsberg, W.Z. Bradford, and G. Oster Incidence and prevalence of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 174 2006 810 816
48. S.D. Nathan, O.A. Shlobin, and N. Weir Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium Chest 140 2011 221 229
49. H. Cole, J. Rauschkolb, and J. Toomey Dyskeratosis congenita with pigmentation, dystrophia unguis and leukokeratosis oris Arch Dermatol Syphilol 21 1930 71 95
50. F. Zinsser Atrophia cutis reticularis cum pigmentatione, dystrophia unguium et leukokeratosis oris Ikonogr Dermatol (Hyoto) 5 1910 219 223
51. M. Engman A unique case of reticular pigmentation of the skin with atrophy Arch Dermatol Syphilol 13 1926 685 687
52. A.J. Walne, and I. Dokal Dyskeratosis congenita: a historical perspective Mech Ageing Dev 129 2008 48 59
53. H.R. Davidson, and J.M. Connor Dyskeratosis congenita J Med Genet 25 1988 843 846
54. J. Bodalski, E. Defecinska, L. Judkiewicz, and M. Pacanowska Fanconi's anaemia and dyskeratosis congenita as a syndrome Dermatologica 127 1963 330 342
55. H.G. Bryan, and R.K. Nixon Dyskeratosis congenita and familial pancytopenia JAMA 192 1965 203 208
56. S. Imokawa, A. Sato, and M. Toyoshima Dyskeratosis congenita showing usual interstitial pneumonia Intern Med 33 1994 226 230
57. F. Verra, S. Kouzan, P. Saiag, J. Bignon, and H. de Cremoux Bronchoalveolar disease in dyskeratosis congenita Eur Respir J 5 1992 497 499
58. A.A. Langston, J.E. Sanders, and H.J. Deeg Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita Br J Haematol 92 1996 758 765
59. M. Yabe, H. Yabe, and K. Hattori Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation Bone Marrow Transplant 19 1997 389 392
60. N. Giri, R. Lee, and A. Faro Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: case report and systematic literature review BMC Blood Disord 11 2011 3
61. J.R. Mitchell, E. Wood, and K. Collins A telomerase component is defective in the human disease dyskeratosis congenita Nature 402 1999 551 555
62. N.S. Heiss, S.W. Knight, and T.J. Vulliamy X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions Nat Genet 19 1998 32 38
63. T.J. Vulliamy, A. Walne, A. Baskaradas, P.J. Mason, A. Marrone, and I. Dokal Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure Blood Cells Mol Dis 34 2005 257 263
64. T. Vulliamy, A. Marrone, and F. Goldman The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita Nature 413 2001 432 435
65. S.A. Savage, B.J. Stewart, and B.B. Weksler Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure Blood Cells Mol Dis 37 2006 134 136
66. T. Vulliamy, A. Marrone, R. Szydlo, A. Walne, P.J. Mason, and I. Dokal Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC Nat Genet 36 2004 447 449
67. S.W. Knight, T.J. Vulliamy, B. Morgan, K. Devriendt, P.J. Mason, and I. Dokal Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis Hum Genet 108 2001 299 303
68. M. Armanios, J.L. Chen, and Y.P. Chang Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita Proc Natl Acad Sci U S A 102 2005 15960 15964
69. H. Yamaguchi, R.T. Calado, and H. Ly Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia N Engl J Med 352 2005 1413 1424
70. S.A. Savage, and B.P. Alter Dyskeratosis congenita Hematol Oncol Clin North Am 23 2009 215 231
71. S. Knight, T. Vulliamy, A. Copplestone, E. Gluckman, P. Mason, and I. Dokal Dyskeratosis Congenita (DC) Registry: identification of new features of DC Br J Haematol 103 1998 990 996
72. M.Y. Armanios, J.J. Chen, and J.D. Cogan Telomerase mutations in families with idiopathic pulmonary fibrosis N Engl J Med 356 2007 1317 1326
73. K.D. Tsakiri, J.T. Cronkhite, and P.J. Kuan Adult-onset pulmonary fibrosis caused by mutations in telomerase Proc Natl Acad Sci U S A 104 2007 7552 7557
74. T. Mushiroda, S. Wattanapokayakit, and A. Takahashi A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis J Med Genet 45 2008 654 656
75. B.A. Fernandez, G. Fox, and R. Bhatia A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features Respir Res 13 2012 64
76. J.K. Alder, J.J. Chen, and L. Lancaster Short telomeres are a risk factor for idiopathic pulmonary fibrosis Proc Natl Acad Sci U S A 105 2008 13051 13056
77. A. Marrone, D. Stevens, T. Vulliamy, I. Dokal, and P.J. Mason Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency Blood 104 2004 3936 3942
78. A. Marrone, P. Sokhal, and A. Walne Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations Haematologica 92 2007 1013 1020
79. H.Y. Du, E. Pumbo, and P. Manley Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene Blood 111 2008 1128 1130
80. J.M. Gansner, I.O. Rosas, and B.L. Ebert Pulmonary fibrosis, bone marrow failure, and telomerase mutation N Engl J Med 366 2012 1551 1553
81. A. Diaz de Leon, J.T. Cronkhite, and A.L. Katzenstein Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations PLoS One 5 2010 e10680
82. E.M. Parry, J.K. Alder, X. Qi, J.J. Chen, and M. Armanios Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase Blood 117 2011 5607 5611
83. R.T. Calado, J.A. Regal, and D.E. Kleiner A spectrum of severe familial liver disorders associate with telomerase mutations PLoS One 4 2009 e7926
84. D.C. Chambers, B.E. Clarke, J. McGaughran, and C.K. Garcia Lung fibrosis, premature graying, and macrocytosis Am J Respir Crit Care Med 186 2012 e8 e9
85. H.Y. Du, E. Pumbo, and J. Ivanovich TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements Blood 113 2009 309 316
86. Z.T. Xin, A.D. Beauchamp, and R.T. Calado Functional characterization of natural telomerase mutations found in patients with hematologic disorders Blood 109 2007 524 532
87. S. El-Chemaly, S.G. Ziegler, and R.T. Calado Natural history of pulmonary fibrosis in two subjects with the same telomerase mutation Chest 139 2011 1203 1209
88. M.C. Jongmans, E.T. Verwiel, and Y. Heijdra Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita Am J Hum Genet 90 2012 426 433
89. G.L. Snider, J. Kleinerman, W.M. Thurlbeck, and Z.H. Bengali The definition of emphysema: report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop Am Rev Respir Dis 132 1985 182 185
90. R. Borie, B. Crestani, and H. Bichat Prevalence of telomere shortening in familial and sporadic pulmonary fibrosis is increased in men Am J Respir Crit Care Med 179 2009 1073
91. P.B. Bitterman, S.I. Rennard, B.A. Keogh, M.D. Wewers, S. Adelberg, and R.G. Crystal Familial idiopathic pulmonary fibrosis: evidence of lung inflammation in unaffected family members N Engl J Med 314 1986 1343 1347
92. G. Raghu, K.J. Anstrom, T.E. King Jr., J.A. Lasky, and F.J. Martinez Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis N Engl J Med 366 2012 1968 1977
93. H.I. Adamali, and T.M. Maher Current and novel drug therapies for idiopathic pulmonary fibrosis Drug Des Devel Ther 6 2012 261 271
94. J.D. Christie, L.B. Edwards, and A.Y. Kucheryavaya The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report: 2012 J Heart Lung Transplant 31 2012 1073 1086
95. E.S. Weiss, J.G. Allen, C.A. Merlo, J.V. Conte, and A.S. Shah Survival after single versus bilateral lung transplantation for high-risk patients with pulmonary fibrosis Ann Thorac Surg 88 2009 1616 1625 discussion 25-6
96. T.J. George, G.J. Arnaoutakis, and A.S. Shah Lung transplant in idiopathic pulmonary fibrosis Arch Surg 146 2011 1204 1209
97. R. Peffault de Latour, R.T. Calado, and M. Busson Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation Blood 120 2012 3353 3359
98. B.R. Celli, and W. MacNee Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946
99. Chronic obstructive pulmonary disease among adults: United States, 2011 MMWR Morb Mortal Wkly Rep 61 2012 938 943
100. J. Lee, A.J. Sandford, and J.E. Connett The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD) PLoS One 7 2012 e35567
101. M. Chilosi, V. Poletti, and A. Rossi The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res 13 2012 3
102. K. Ito, and P.J. Barnes COPD as a disease of accelerated lung aging Chest 135 2009 173 180
103. J. Lee, A. Sandford, P. Man, and D.D. Sin Is the aging process accelerated in chronic obstructive pulmonary disease? Curr Opin Pulm Med 17 2011 90 97
104. T. Tsuji, K. Aoshiba, and A. Nagai Alveolar cell senescence in patients with pulmonary emphysema Am J Respir Crit Care Med 174 2006 886 893
105. T. Tsuji, K. Aoshiba, and A. Nagai Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease Respiration 80 2010 59 70
106. T.S. Mui, J.M. Man, and J.E. McElhaney Telomere length and chronic obstructive pulmonary disease: evidence of accelerated aging J Am Geriatr Soc 57 2009 2372 2374
107. W. MacNee Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD) Biochem Soc Trans 37 2009 819 823
108. L. Savale, A. Chaouat, and S. Bastuji-Garin Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 179 2009 566 571
109. J.M. Houben, E.M. Mercken, and H.B. Ketelslegers Telomere shortening in chronic obstructive pulmonary disease Respir Med 103 2009 230 236
110. V. Amsellem, G. Gary-Bobo, and E. Marcos Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 184 2011 1358 1366
111. L. Rode, S.E. Bojesen, M. Weischer, J. Vestbo, and B.G. Nordestgaard Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals Thorax 68 2012 429 435
112. M. Morla, X. Busquets, J. Pons, J. Sauleda, W. MacNee, and A.G. Agusti Telomere shortening in smokers with and without COPD Eur Respir J 27 2006 525 528
113. T.S. Nawrot, J.A. Staessen, and P. Holvoet Telomere length and its associations with oxidized-LDL, carotid artery distensibility and smoking Front Biosci (Elite Ed) 2 2010 1164 1168
114. M. Shen, R. Cawthon, and N. Rothman A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer Lung Cancer 73 2011 133 137
115. T.E. Strandberg, O. Saijonmaa, and R.S. Tilvis Association of telomere length in older men with mortality and midlife body mass index and smoking J Gerontol A Biol Sci Med Sci 66 2011 815 820
116. X. Kong, M.H. Cho, and W. Anderson Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema Am J Respir Crit Care Med 183 2011 43 49
117. M. Mangino, S. Brouilette, and P. Braund A regulatory SNP of the BICD1 gene contributes to telomere length variation in humans Hum Mol Genet 17 2008 2518 2523
118. J.K. Alder, N. Guo, and F. Kembou Telomere length is a determinant of emphysema susceptibility Am J Respir Crit Care Med 184 2011 904 912
119. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
120. S. Lantuejoul, J.C. Soria, and D. Moro-Sibilot Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours Br J Cancer 90 2004 1222 1229
121. S. Lantuejoul, C. Salon, J.C. Soria, and E. Brambilla Telomerase expression in lung preneoplasia and neoplasia Int J Cancer 120 2007 1835 1841
122. C.B. Harley Telomerase is not an oncogene Oncogene 21 2002 494 502
123. C.P. Morales, S.E. Holt, and M. Ouellette Absence of cancer-associated changes in human fibroblasts immortalized with telomerase Nat Genet 21 1999 115 118
124. B.P. Alter, N. Giri, S.A. Savage, and P.S. Rosenberg Cancer in dyskeratosis congenita Blood 113 2009 6549 6557
125. J.D. McKay, R.J. Hung, and V. Gaborieau Lung cancer susceptibility locus at 5p15.33 Nat Genet 40 2008 1404 1406
126. Q. Lan, C.A. Hsiung, and K. Matsuo Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia Nat Genet 44 2012 1330 1335
127. C.A. Hsiung, Q. Lan, and Y.C. Hong The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia PLoS Genet 6 2010:e1001051
128. M.T. Landi, N. Chatterjee, and K. Yu A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma Am J Hum Genet 85 2009 679 691
129. D. Miki, M. Kubo, and A. Takahashi Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations Nat Genet 42 2010 893 896
130. Z. Hu, C. Wu, and Y. Shi A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese Nat Genet 43 2011 792 796
131. T. Truong, R.J. Hung, and C.I. Amos Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium J Natl Cancer Inst 102 2010 959 971
132. M.A. James, W. Wen, and Y. Wang Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus PLoS One 7 2012 e36116
133. J.S. Jang, Y.Y. Choi, and W.K. Lee Telomere length and the risk of lung cancer Cancer Sci 99 2008 1385 1389
134. X. Wu, C.I. Amos, and Y. Zhu Telomere dysfunction: a potential cancer predisposition factor J Natl Cancer Inst 95 2003 1211 1218
135. H.D. Hosgood III, R. Cawthon, X. He, S. Chanock, and Q. Lan Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility Lung Cancer 66 2009 157 161
136. H.S. Jeon, Y.Y. Choi, and J.E. Choi Telomere length of tumor tissues and survival in patients with early stage non-small cell lung cancer Mol Carcinog 2012 10.1002/mc.21972
137. C. Frias, C. Garcia-Aranda, and C. De Juan Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer Lung Cancer 60 2008 416 425
138. T. Hirashima, T. Komiya, and T. Nitta Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer Anticancer Res 20 2000 2181 2187
139. T. Targowski, K. Jahnz-Rozyk, T. Szkoda, T. Plusa, and S. From Telomerase activity in transthoracic fine-needle biopsy aspirates from non-small cell lung cancer as prognostic factor of patients' survival Lung Cancer 61 2008 97 103
140. T.C. Wu, P. Lin, and C.P. Hsu Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas Lung Cancer 41 2003 163 169
141. K.Y. Chen, L.N. Lee, C.J. Yu, Y.C. Lee, S.H. Kuo, and P.C. Yang Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer Cancer Lett 240 2006 148 156
142. A. Marchetti, G. Bertacca, and F. Buttitta Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer Clin Cancer Res 5 1999 2077 2081
143. S. Taga, T. Osaki, A. Ohgami, H. Imoto, and K. Yasumoto Prognostic impact of telomerase activity in non-small cell lung cancers Ann Surg 230 1999 715 720
144. C.Q. Zhu, J.C. Cutz, and N. Liu Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer Br J Cancer 94 2006 1452 1459
145. Y. Fujita, T. Fujikane, and S. Fujiuchi The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma Cancer 98 2003 1008 1013
146. R. Gonzalez-Quevedo, P. Iniesta, and A. Moran Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer J Clin Oncol 20 2002 254 262
147. C.P. Hsu, J. Miaw, S.E. Shai, and C.Y. Chen Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer: an adjusted measurement and its clinical significance Eur J Cardiothorac Surg 26 2004 425 431
148. M. Ruden, and N. Puri Novel anticancer therapeutics targeting telomerase Cancer Treat Rev 2012
149. J.W. Shay, R.R. Reddel, and W.E. Wright Cancer: cancer and telomeres - an ALTernative to telomerase Science 336 2012 1388 1390
150. C.M. Heaphy, A.P. Subhawong, and S.M. Hong Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes Am J Pathol 179 2011 1608 1615
151. R.B. Effros Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress Exp Gerontol 46 2011 135 140
152. M. Dagarag, T. Evazyan, N. Rao, and R.B. Effros Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization J Immunol 173 2004 6303 6311
153. S.R. Fauce, B.D. Jamieson, and A.C. Chin Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes J Immunol 181 2008 7400 7406
154. R.B. Effros, M. Dagarag, C. Spaulding, and J. Man The role of CD8+ T-cell replicative senescence in human aging Immunol Rev 205 2005 147 157
155. J.Z. Guan, T. Maeda, and M. Sugano An analysis of telomere length in sarcoidosis J Gerontol A Biol Sci Med Sci 62 2007 1199 1203